Toxicities Associated with Ribociclib From MONALEESA-3 TrialByPatrick Neven, MD, PhDOctober 15th 2019Overall survival results from the MONALESSA-3 phase III trial showed positive results for patients with advanced breast cancer, but toxicities related to the use of ribociclib still need to be addressed.